Objects
Lim, Belle W. X., Li, Na, Devereux, Lisa, Scott, Rodney J., Sloan, Erica K., James, Paul A., Campbell, Ian G., Mahale, Sakshi, McInerny, Simone, Zethoven, Magnus, Rowley, Simone M., Huynh, Joanne, Wang, Theresa, Lee, Jue Er Amanda, Friedman, Mia. Oxford University Press; 2023. Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants.
Lim, Belle W. X., Li, Na, Rowley, Simone M., Thompson, Ella R., McInerny, Simone, Zethoven, Magnus, Scott, Rodney J., Devereux, Lisa, Sloan, Erica K., James, Paul A., Campbell, Ian G.. Nature Publishing Group; 2022. Integration of tumour sequencing and case–control data to assess pathogenicity of RAD51C missense variants in familial breast cancer.
Li, Na, Zethoven, Magnus, Nguyen-Dumont, Tu, Southey, Melissa C., Hopper, John L., Simard, Jacques, Dumont, Martine, Soucy, Penny, Meindl, Alfons, Schmutzler, Rita, Schmidt, Marjanka K., Adank, Muriel A., McInerny, Simone, Andrulis, Irene L., Hahnen, E, Engel, C, Lesueur, F, Girard, E, Neuhausen, SL, Ziv, E, Allen, J, Easton, DF, Scott, Rodney J., Devereux, Lisa, Gorringe, KL, James, PA, Campbell, IG, Huang, Yu-Kuan, Thio, Niko, Cheasley, Dane, Gutiérrez-Enríquez, Sara, Moles-Fernández, Alejandro, Diez, Orland. Nature Publishing Group; 2021. Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.
Li, Na, Lim, Belle W. X., Thompson, Ella R., McInerny, Simone, Zethoven, Magnus, Cheasley, Dane, Rowley, Simone M., Wong-Brown, Michelle W., Devereux, Lisa, Gorringe, Kylie L., Sloan, Erica K., Trainer, Alison, Scott, Rodney J., James, Paul A., Campbell, Ian G.. Nature Publishing Group; 2021. Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study.
Li, Na, Zethoven, Magnus, McInerny, Simone, Healey, Eliza, DeSilva, Dilanka, Devereux, Lisa, Scott, Rodney J., James, Paula A., Campbell, Ian G.. BMJ Group; 2023. Contribution of large genomic rearrangements in PALB2 to familial breast cancer: Implications for genetic testing.